Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of Interferon Gamma-1b for the Treatment of Autosomal Dominant Type 2 Osteopetrosis

NCT02584608 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT02584608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02584608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of Interferon Gamma-1b for the Treatment of Autosomal Dominant Type 2 Osteopetrosis
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2016
Completion date
November 12, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant osteopetrosis type 2